search
Back to results

Erector Spinae Plane Block (ESP) Versus Thoracic Epidural Anesthesia in Video-Assisted Thoracoscopic Surgery (VATS) in Pediatric Population; a Randomized, Controlled Study (ESP)

Primary Purpose

Pain, Postoperative

Status
Unknown status
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Erector Spinae Plane Block
Sponsored by
Vittore Buzzi Children's Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain, Postoperative

Eligibility Criteria

1 Month - 10 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ASA I-III
  • Scheduled for Video-Assisted Thoracoscopic Procedure
  • Parental consent

Exclusion Criteria:

  • Parental refusal
  • History of allergy to local anesthetics
  • Systemic coagulopathy
  • Local infection at puncture site
  • Severe renal or liver disease
  • Known rib cage malformations

Sites / Locations

  • Children's Hospital Vittore Buzzi

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Erector Spinae plane Block

Thoracic Epidural Anesthesia

Arm Description

After induction of general anesthesia, patients will be positioned in lateral decubitus with surgical site up and the transverse process of T5-T7 vertebrae and Erector Spinae (ES) fascia will be located with a linear ultrasound probe. A 19G or 20G epidural needle (according to age) will be positioned under the ES muscle and a bolus of of 0.3-0.5ml/kg of 0.2% ropivacaine will be administered; after hydrodissection, the catheter will be threaded, followed by an infusion of 0.2mg/kg/hr for the next 48 hours.

After induction of general anesthesia, patients will be positioned in lateral decubitus with surgical site up and a 19G or 20G epidural needle (according to age) will be positioned at T5-T7 level with cathether placement; a bolus of of 0.3-0.5ml/kg of 0.2% ropivacaine will be administered and followed by an infusion of 0.2mg/kg/hr for the next 48 hours.

Outcomes

Primary Outcome Measures

Post-operative pain
Postoperative pain will be assessed by FLACC (Face, Legs, Activity: Cry, Consolability) scale for children aged 1-5 years, and NRS (numerical rating scale) for children aged 6-10 years

Secondary Outcome Measures

Intraoperative opiod use
Total amount of intraoperative opiods
Postoperative opiod consumption
Determine if ESP will decrease postoperative opioid consumption compared to Thoracic Epidural Anesthesia

Full Information

First Posted
May 4, 2021
Last Updated
May 6, 2021
Sponsor
Vittore Buzzi Children's Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04878341
Brief Title
Erector Spinae Plane Block (ESP) Versus Thoracic Epidural Anesthesia in Video-Assisted Thoracoscopic Surgery (VATS) in Pediatric Population; a Randomized, Controlled Study
Acronym
ESP
Official Title
Erector Spinae Plane Block (ESP) Versus Thoracic Epidural Anesthesia in Video-Assisted Thoracoscopic Surgery (VATS) in Pediatric Population; a Randomized, Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
May 2021
Overall Recruitment Status
Unknown status
Study Start Date
July 2021 (Anticipated)
Primary Completion Date
December 2022 (Anticipated)
Study Completion Date
April 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Vittore Buzzi Children's Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Aim of the study is to investigate the efficacy and safety of continuous ESP block in children under the age of 10 yrs undergoing video-assisted thoracoscopic procedures, compared to Thoracic Epidural Anesthesia (TEA).
Detailed Description
Primary outcome: Post-operative pain assessed by FLACC (Face, Legs, Activity: Cry, Consolability) for children age 1-5 years, and NRS (numerical rating scale) for children age 6-10 years Secondary outcomes: Opioid consumption for 48 hours post-operatively. Intraoperative opiod use Block failure rate (defined as Heart Rate (HR) increase of more than 20% of baseline at surgical incision) Time to extubation after surgery completion After parental consent, children aged 0-10 yrs scheduled for unilateral VATS procedure will be randomized into two groups: Thoracic Epidural Group (TEA) vs Erector Spinae Plane block (ESP). Children with history of allergy to local anesthetics, systemic coagulopathy, infection at site of puncture, severe renal or liver disease, known rib cage malformations will be excluded from the study. Anesthesia will be induced at operator's preference; before surgery beginning children will be positioned and either TEA or ESP will be performed. In both cases, a bolus of of 0.3-0.5ml/kg of 0.2% ropivacaine will be administered, followed by an infusion of 0.2mg/kg/hr for the next 48 hours. The time from block placement to incision will be recorded, change in HR before and after incision will be documented, need for intraoperative opiod use, time to first rescue analgesic, and total amount of local anesthetic given at 24 h and 48 h post-operatively will be recorded together with pain measures as specified. Opiods will be prescribed if child presents with FLACC scores > 3 (FLACC score of 0-3 = mild pain, 4-6 = moderate, 7-10 = severe), or VAS >5. Total opioid consumption will be recorded. Statistical analysis Intention to treat analysis will be performed. Quantitative variables will be described as mean and standard deviation (sd) or median and interquartile range (IQR) if not normally distributed (Shapiro-Wilks test) For primary outcome, VAS or FLACC score will be compared with t-test or Mann-Whitney test Opioid consumption will be compared with t-test or Mann-Whitney test Block failure rate will be compared with chi2 test Time to extubation will be compared with log rank test Sample size With 37 patients for group a power of 80% will be achieved to identify as significant a difference in mean pain score when sd is 1,5 times greater than mean. Alpha error will be 0.05 and a two-sample t-test will be applied. Randomization A random block centralized randomization list will be generated before study start with Ralloc command in Stata. It will be stratified by center. To avoid allocation concealment the closed envelope method will be used.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Postoperative

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
74 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Erector Spinae plane Block
Arm Type
Experimental
Arm Description
After induction of general anesthesia, patients will be positioned in lateral decubitus with surgical site up and the transverse process of T5-T7 vertebrae and Erector Spinae (ES) fascia will be located with a linear ultrasound probe. A 19G or 20G epidural needle (according to age) will be positioned under the ES muscle and a bolus of of 0.3-0.5ml/kg of 0.2% ropivacaine will be administered; after hydrodissection, the catheter will be threaded, followed by an infusion of 0.2mg/kg/hr for the next 48 hours.
Arm Title
Thoracic Epidural Anesthesia
Arm Type
Active Comparator
Arm Description
After induction of general anesthesia, patients will be positioned in lateral decubitus with surgical site up and a 19G or 20G epidural needle (according to age) will be positioned at T5-T7 level with cathether placement; a bolus of of 0.3-0.5ml/kg of 0.2% ropivacaine will be administered and followed by an infusion of 0.2mg/kg/hr for the next 48 hours.
Intervention Type
Other
Intervention Name(s)
Erector Spinae Plane Block
Intervention Description
The ESP is fascial plane block performed by injecting local anesthetic between the erector spinae muscle and the transverse process. Its proposed mechanism of action is via blockade of the dorsal and ventral rami of the thoracic spinal nerves and sympathetic fibers.
Primary Outcome Measure Information:
Title
Post-operative pain
Description
Postoperative pain will be assessed by FLACC (Face, Legs, Activity: Cry, Consolability) scale for children aged 1-5 years, and NRS (numerical rating scale) for children aged 6-10 years
Time Frame
First 48 hours after surgery
Secondary Outcome Measure Information:
Title
Intraoperative opiod use
Description
Total amount of intraoperative opiods
Time Frame
Surgery duration
Title
Postoperative opiod consumption
Description
Determine if ESP will decrease postoperative opioid consumption compared to Thoracic Epidural Anesthesia
Time Frame
First 48 hours after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Month
Maximum Age & Unit of Time
10 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ASA I-III Scheduled for Video-Assisted Thoracoscopic Procedure Parental consent Exclusion Criteria: Parental refusal History of allergy to local anesthetics Systemic coagulopathy Local infection at puncture site Severe renal or liver disease Known rib cage malformations
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Anna Camporesi, MD
Phone
+393355793744
Email
anna.camporesi@asst-fbf-sacco.it
First Name & Middle Initial & Last Name or Official Title & Degree
Veronica Diotto, MD
Phone
+390563635157
Email
veronica.diotto@asst-fbf-sacco.it
Facility Information:
Facility Name
Children's Hospital Vittore Buzzi
City
Milan
ZIP/Postal Code
20154
Country
Italy
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anna Camporesi, MD
Phone
+393355793744
Email
anna.camporesi@asst-fbf-sacco.it
First Name & Middle Initial & Last Name & Degree
Veronica Diotto, MD
Phone
+390263635157
Email
veronica.diotto@asst-fbf-sacco.it

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
32900720
Citation
Swenson Schalkwyk A, Flaherty J, Hess D, Horvath B. Erector spinae catheter for post-thoracotomy pain control in a premature neonate. BMJ Case Rep. 2020 Sep 7;13(9):e234480. doi: 10.1136/bcr-2020-234480.
Results Reference
background
PubMed Identifier
29370900
Citation
Gaio-Lima C, Costa CC, Moreira JB, Lemos TS, Trindade HL. Continuous erector spinae plane block for analgesia in pediatric thoracic surgery: A case report. Rev Esp Anestesiol Reanim (Engl Ed). 2018 May;65(5):287-290. doi: 10.1016/j.redar.2017.11.010. Epub 2018 Jan 19. English, Spanish.
Results Reference
background
PubMed Identifier
29226529
Citation
De la Cuadra-Fontaine JC, Concha M, Vuletin F, Arancibia H. Continuous Erector Spinae Plane block for thoracic surgery in a pediatric patient. Paediatr Anaesth. 2018 Jan;28(1):74-75. doi: 10.1111/pan.13277. No abstract available.
Results Reference
background
PubMed Identifier
30844822
Citation
Patel NV, Glover C, Adler AC. Erector Spinae Plane Catheter for Postoperative Analgesia After Thoracotomy in a Pediatric Patient: A Case Report. A A Pract. 2019 May 1;12(9):299-301. doi: 10.1213/XAA.0000000000000914.
Results Reference
background
PubMed Identifier
31883421
Citation
Holland EL, Bosenberg AT. Early experience with erector spinae plane blocks in children. Paediatr Anaesth. 2020 Feb;30(2):96-107. doi: 10.1111/pan.13804. Epub 2020 Jan 27.
Results Reference
background

Learn more about this trial

Erector Spinae Plane Block (ESP) Versus Thoracic Epidural Anesthesia in Video-Assisted Thoracoscopic Surgery (VATS) in Pediatric Population; a Randomized, Controlled Study

We'll reach out to this number within 24 hrs